These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1322467)
1. From the Food and Drug Administration. Nightingale SL JAMA; 1992 Aug; 268(6):705. PubMed ID: 1322467 [No Abstract] [Full Text] [Related]
2. FDA Committee recommends clearance for HIVID combination therapy. AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361630 [No Abstract] [Full Text] [Related]
3. Combination therapy for HIV infection: getting closer. Fauci AS Ann Intern Med; 1992 Jan; 116(1):85-6. PubMed ID: 1309202 [No Abstract] [Full Text] [Related]
4. Special drug communication teleconference. August 7, 1992. Ear Nose Throat J; 1992 Sep; 71(9):383-4, 387-90. PubMed ID: 1425376 [No Abstract] [Full Text] [Related]
5. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group. Lancet; 1999 Jun; 353(9169):2014-25. PubMed ID: 10376616 [TBL] [Abstract][Full Text] [Related]
6. More HIV patients may benefit from zalcitabine now. RN; 1995 Jan; 58(1):66. PubMed ID: 7624706 [No Abstract] [Full Text] [Related]
7. Combination drug treatment benefits patients with HIV. Boulton A BMJ; 1996 Aug; 313(7053):320. PubMed ID: 8760735 [No Abstract] [Full Text] [Related]
8. A new HIV/AIDS drug. J Ark Med Soc; 1996 Jan; 92(8):407. PubMed ID: 8582889 [No Abstract] [Full Text] [Related]
9. Crixivan reduces viral load. AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361665 [No Abstract] [Full Text] [Related]
10. Potent new AIDS drugs underscore promise of combination therapy. AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225 [TBL] [Abstract][Full Text] [Related]
11. [Anti-HIV therapy (1987-1994): from nothing to confusion]. Lissen E Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285 [No Abstract] [Full Text] [Related]
12. 3TC/AZT: just another combination. GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997 [TBL] [Abstract][Full Text] [Related]
13. 3TC and saquinavir: we need them now. Baker R BETA; 1995 Sep; ():3. PubMed ID: 11362889 [TBL] [Abstract][Full Text] [Related]
14. Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations. Izopet J; Sailler L; Sandres K; Pasquier C; Bonnet E; Aquilina C; Puel J; Massip P; Marchou B J Med Virol; 1999 Feb; 57(2):163-8. PubMed ID: 9892402 [TBL] [Abstract][Full Text] [Related]
16. [What should be done after needlestick injuries with possible HIV exposure?]. Marcus U Fortschr Med; 1996 Feb; 114(4):23-4. PubMed ID: 8852682 [No Abstract] [Full Text] [Related]
19. Safety of terfenadine and astemizole. Med Lett Drugs Ther; 1992 Feb; 34(863):9-10. PubMed ID: 1732711 [No Abstract] [Full Text] [Related]
20. Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3. Ibáñez A; Peraire J; Arnó A; Gutiérrez C; Cervantes M; Colomer J; Villalonga C; Camafort M; Ruiz L; Balaguer M; Vidal F; Richart C; Clotet B Antivir Ther; 1997 Apr; 2(2):105-11. PubMed ID: 11322274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]